Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines

International Journal of Pharmaceutics

Volumn 420, Issue 1, 2011, Pages 93-100

  Pardeike, Jana ^a   Strohmeier, Daniela M ^a,b   Schrödl, Nina ^b   Voura, Christine ^b   Gruber, Michael ^b   Khinast, Johannes G ^b   Zimmer, Andreas ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH   (Austria)

Author keywords

Dissolution velocity; Folic acid; Inkjet type printing technique; Nanosuspension; Personalized medicine; Saturation solubility

Indexed keywords

CREMOPHOR; DODECYL SULFATE SODIUM; FOLIC ACID; POLOXAMER; POLYSORBATE 20; POLYSORBATE 40; POLYSORBATE 80; SOLUTOL HS 15; WATER;

ARTICLE; CONTACT ANGLE; CONTROLLED STUDY; CRYSTALLIZATION; DOSE CALCULATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; HOMOGENIZATION; HYPERBARISM; NANOSUSPENSION; PARTICLE SIZE; PERSONALIZED MEDICINE; PHARMACOLOGICAL PROCEDURES; PRIORITY JOURNAL; REPRODUCIBILITY; SUSPENSION; ZETA POTENTIAL;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DOSAGE FORMS; DRUG COMPOUNDING; DRUG DOSAGE CALCULATIONS; DRUG STABILITY; EXCIPIENTS; FOLIC ACID; HUMANS; INDIVIDUALIZED MEDICINE; KINETICS; NANOPARTICLES; NANOTECHNOLOGY; POLYSORBATES; PRESSURE; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; WETTING AGENTS;

EID: 80054704988     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.08.033     Document Type: Article

References (40)

1. E.K. Anderberg, C. Nyström, and M. Bisrat Physicochemical aspects of drug release VII. The effect of surfactant concentration and drug particle size on solubility and dissolution rate of felodipine, a sparingly soluble drug Int. J. Pharm. 47 1988 67 77
2. R. Ambrus, P. Kocbek, J. Kristl, R. Sibanc, R. Rajko, and P. Szabo-Revesz Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam Int. J. Pharm. 381 2009 153 159
3. A.M. Cerdeira, M. Mazzotti, and B. Gander Miconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stability Int. J. Pharm. 396 2010 210 218
4. A. Dolenc, B. Govedarica, R. Dreu, P. Kocbek, S. Srcic, and J. Kristl Nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition Int. J. Pharm. 396 2010 149 155
5. D. Giron Thermal analysis and calorimetric methods in the characterisation of polymorphs and solvates Thermochim. Acta 248 1995 1 59
6. D.J.W. Grant, and H.G. Brittain Solubility of pharmaceutical solids H.G. Brittain, Physical Characterization of Pharmaceutical Solids 1995 Marcel Dekker New York 321 386
7. M.J. Grau, O. Kayser, and R.H. Müller Nanosuspensions of poorly soluble drugs - reproducibility of small scale production Int. J. Pharm. 196 2000 155 159 (Pubitemid 30105733)
8. A. Grunenberg Polymorphism and thermal analysis of pharmaceutical agents Pharm. Unserer Z. 26 1997 224 231 (Pubitemid 27514542)
9. O. Heudi, T. Kilinc, and P. Fontannaz Separation of water-soluble vitamins by reversed-phase high performance liquid chromatography with ultra-violet detection: application to polyvitaminated premixes J. Chromatogr. A 1070 2005 49 56 (Pubitemid 40417766)
10. C. Jacobs, and R.H. Müller Production and characterization of a budesonide nanosuspension for pulmonary administration Pharm. Res. 19 2002 189 194 (Pubitemid 34165405)
11. D. Jang, D. Kim, and J. Moon Influence of fluid physical properties on ink-jet printability Langmuir 25 2009 2629 2635
12. C.M. Keck, and R.H. Müller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16 (Pubitemid 41736019)
13. J.E. Kipp The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs Int. J. Pharm. 284 2004 109 122 (Pubitemid 39349144)
14. H.P. Latscha, and H.A. Klein Analytische Chemie 1995 Springer Verlag Berlin/Heidelberg
15. E.R. Lee Fluid engineering of microdrop ejectors S.E. Lyshevski, Microdrop Generation 2003 CRC Press LCC 177 188
16. X. Li, L. Gu, Y. Xu, and Y. Wang Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats Drug Dev. Ind. Pharm. 35 2009 827 833
17. R. Mauludin, R.H. Müller, and C.M. Keck Kinetic solubility and dissolution velocity of rutin nanocrystals Eur. J. Pharm. Sci. 36 2009 502 510
18. E.M. Merisko-Liversidge, and G.G. Liversidge Drug nanoparticles: formulating poorly water-soluble compounds Toxicol. Pathol. 36 2008 43 48
19. E. Merisko Liversidge nanocrystals: resolving pharmaceutical formulation issues associated with poorly water-soluble compounds J.J. Marty, Particles 2002 Marcel Dekker Orlando
20. P.R. Mishra, L. Al Shaal, R.H. Müller, and C.M. Keck Production and characterization of Hesperetin nanosuspensions for dermal delivery Int. J. Pharm. 371 2009 182 189
21. J. Möschwitzer, G. Achleitner, H. Pomper, and R.H. Müller Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology Eur. J. Pharm. Biopharm. 58 2004 615 619 (Pubitemid 39297108)
22. J. Möschwitzer, and R.H. Müller Spray coated pellets as carrier system for mucoadhesive drug nanocrystals Eur. J. Pharm. Biopharm. 62 2006 282 287 (Pubitemid 43356577)
23. M. Mosharraf, and C. Nyström The effect of particle size and shape on the surface dissolution rate of micronized practically insoluble drugs Int. J. Pharm. 122 1995 35 47
24. R.H. Müller Zetapotential und Partikelladung in der Laborpraxis 1996 Wissenschaftliche Verlagsgesellschaft Stuttgart
25. R.H. Müller, and A. Akkar Drug nanocrystals of poorly soluble drugs Encyclopedia Nanosci. Nanotechnol. 2 2004 627 638
26. R.H. Müller, and C. Jacobs Buparvaquone mucoadhesive nanosuspensions: preparation, optimisation and long-term stability Int. J. Pharm. 237 2002 151 161 (Pubitemid 34310488)
27. R.H. Müller, C. Jacobs, and O. Kayser Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future Adv. Drug Deliv. Rev. 47 2001 3 19 (Pubitemid 32209229)
28. R.H. Müller, and K. Peters Nanosuspension for the formulation of poorly soluble drugs 1. Preparation by a size-reduction technique Int. J. Pharm. 160 1997 229 237 (Pubitemid 28083096)
29. R.H. Müller, and R. Schuhmann Teilchengrößenmessung in der Laborpraxis 1996 Wissenschaftliche Verlagsgesellschaft mbH Stuttgart
30. P. Ney Zetapotentiale und Flotierbarkeit von Mineralien 1973 Springer Verlag Wien/New York
31. C. Nyström, and M. Bisrat Physicochemical aspects of drug release VIII. The relation between particle size and surface specific dissolution rate in agitated suspensions Int. J. Pharm. 47 1988 223 231
32. J. Pardeike, and R.H. Müller Nanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18 Int. J. Pharm. 391 2010 322 329
33. Peters, K., 1999. Nanosuspensionen-Ein neues Formulierungsprinzip für schwerlösliche Arzneistoffe. PhD, Freie Universität Berlin, Berlin.
34. T.M. Riddick Zeta-Meter Manual 1968 Zeta-Meter Inc. New York
35. R. Shegokar, and R.H. Müller Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives Int. J. Pharm. 399 2010 129 139
36. V. Teeranachaideekul, V.B. Junyaprasert, E.B. Souto, and R.H. Müller Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology Int. J. Pharm. 354 2008 227 234
37. A. Vora, A. Riga, D. Dollimore, and S.A. Kenneth Thermal stability of folic acid Thermochim. Acta 392-393 2002 209 220
38. C. Voura, N. Schroedl, M.M. Gruber, D. Strohmeier, B. Eitzinger, W. Bauer, G. Brenn, J.G. Khinast, and A. Zimmer Printable medicines: a microdosing device for producing personalised medicines Pharma Technol. Eur. 23 2011 32 36
39. Y. Wang, Z. Liu, D. Zhang, X. Gao, X. Zhang, C. Duan, L. Jia, F. Feng, Y. Huang, Y. Shen, and Q. Zhang Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension Colloids Surf. B Biointerfaces 83 2011 189 197
40. D. Xia, P. Quan, H. Piao, S. Sun, Y. Yin, and F. Cui Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability Eur. J. Pharm. Sci. 40 2010 325 334